Request Deal Involvement

Sanofi acquired Bioverativ for $10.8bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

H/Advisors Abernathy

pr advisors

H/Advisors Abernathy

Weil Gotshal and Manges

legal advisors

Weil Gotshal and Manges

Lazard

financial advisors

Lazard

Guggenheim Partners

financial advisors

Guggenheim Partners

JP Morgan

financial advisors

JP Morgan

Debevoise & Plimpton

legal advisors to financial advisors

Debevoise & Plimpton

Paul Weiss Rifkind Wharton & Garrison

legal advisors

Paul Weiss Rifkind Wharton & Garrison

Skadden Arps Slate Meagher & Flom

legal advisors

Skadden Arps Slate Meagher & Flom

Sard Verbinnen & Co

pr advisors

Sard Verbinnen & Co

or

Principals

SANOFI SA

bidder

SANOFI SA

BIOVERATIV INC

target

BIOVERATIV INC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite